In the coming years, the Global Retinal Gene Therapy Industry is poised for substantial growth, driven by factors that underscore the rising demand for efficient therapeutic solutions. Recent in-depth market research conducted by [Your Company Name or FMI] indicates a projected Compound Annual Growth Rate (CAGR) of 9.2% over the forecast period, culminating in a …